Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland.
about
sameAs
An economic model of long-term use of celecoxib in patients with osteoarthritisA comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an exampleCost-effectiveness analyses of osteoarthritis oral therapies: a systematic review.Principles for evidence-based drug formulary policy.The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi ArabiaHave COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?Economic outcomes for celecoxib: a systematic review of pharmacoeconomic studies.Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.Understanding and anticipating lag-time bias in cost-effectiveness studies: the role of time in cost-effectiveness analysis.Modelling the complete continuum of care using system dynamics: the case of osteoarthritis in Alberta
P2860
Q28218005-46750333-68D1-4291-85FD-709C778C4D8BQ28472098-3AC22E76-C71D-4DEA-A50B-1CE22F09BFC7Q34384075-A31DF213-5CCC-4090-AD74-69812EEC41C9Q34724227-F40DEBBD-33D2-464A-BED2-36E6D97FA619Q35743672-0BCB4380-7ECF-4613-A925-DBA55008E63AQ35825968-E13F32F5-687F-4D14-ADA2-441294FE7B10Q38042714-82497420-EC4A-421A-9EE4-B81895495AD0Q45347178-FCC15AB5-380D-4737-B36D-EAC15BF630C6Q50594456-39D96E10-1864-4DFD-BAC1-8FFA3DA15954Q57759101-8D5BA75D-5203-4620-891A-1F3496029241
P2860
Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Economic Evaluation of Celecox ...... ific Inhibitor, in Switzerland
@nl
Economic evaluation of celecox ...... fic inhibitor, in Switzerland.
@ast
Economic evaluation of celecox ...... fic inhibitor, in Switzerland.
@en
type
label
Economic Evaluation of Celecox ...... ific Inhibitor, in Switzerland
@nl
Economic evaluation of celecox ...... fic inhibitor, in Switzerland.
@ast
Economic evaluation of celecox ...... fic inhibitor, in Switzerland.
@en
altLabel
Economic Evaluation of Celecox ...... ific Inhibitor, in Switzerland
@en
prefLabel
Economic Evaluation of Celecox ...... ific Inhibitor, in Switzerland
@nl
Economic evaluation of celecox ...... fic inhibitor, in Switzerland.
@ast
Economic evaluation of celecox ...... fic inhibitor, in Switzerland.
@en
P2093
P1433
P1476
Economic Evaluation of Celecox ...... ific Inhibitor, in Switzerland
@en
Economic evaluation of celecox ...... fic inhibitor, in Switzerland.
@en
P2093
Chancellor JV
Edith de Cruz
Elke Hunsche
Fran??ois P. Sarasin
Jeremy V.M. Chancellor
Sarasin FP
P2860
P356
10.2165/00019053-200119001-00005
P433
Supplement 1
P577
2001-01-01T00:00:00Z
P6179
1033783164